Wellington Management Group
ALNA

Wellington Management Group’s Allena Pharmaceuticals ALNA Stock Holding History

Wellington Management Group’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-678,883
Closed -$8.85M – 2351
2018
Q2 		$8.85M Sell
678,883
-78,800
-10% -$1.14M ﹤0.01% 1323
2018
Q1 		$8.35M Hold
757,683
– – ﹤0.01% 1329
2017
Q4 		$7.62M Buy
+757,683
New +$9.34M ﹤0.01% 1352

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group's ALNA Position: Q3 2018 in Review

Wellington Management Group sold out of Allena Pharmaceuticals (ALNA) in Q3 2018, closing a stake of 678,883 shares — an estimated $8.85M sold.

Wellington Management Group first reported a position in ALNA in Q4 2017 and held it in 3 quarters. The position peaked at $8.85M in Q2 2018. 46 funds tracked by Wall St. Rank hold ALNA as of Q3 2018.

  • Wellington Management Group reported no remaining Allena Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Wellington Management Group sold 678,883 Allena Pharmaceuticals shares in Q3 2018, an estimated $8.85M.
  • Wellington Management Group first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Wellington Management Group's Allena Pharmaceuticals position peaked at $8.85M in Q2 2018.
  • 46 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2018.

Based on Wellington Management Group's 13F filing for Q3 2018, filed 14 Nov 2018.